The safety and efficacy of dabrafenib and trametinib in patients with glioma: A systematic review and meta-analysis

ConclusionsDabrafenib and trametinib demonstrate promising anti-tumor efficacy in gliomas, particularly low-grade tumors, achieving durable disease stabilization in many patients. However, toxicity significantly limited tolerability. Additional research should further examine efficacy and refine safe administration protocols across glioma subtypes.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research